首页 > 最新文献

Asian Pacific journal of tropical medicine最新文献

英文 中文
Preventive strategies to innovate Japanese encephalitis control in eastern Uttar Pradesh: Accelerating towards zero incidence 北方邦东部创新日本脑炎控制的预防策略:加速实现零发病
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4103/1995-7645.374352
N. Srivastava, R. Beniwal, B. Misra, Umaer Alam, H. Deval, Rajni Kant
{"title":"Preventive strategies to innovate Japanese encephalitis control in eastern Uttar Pradesh: Accelerating towards zero incidence","authors":"N. Srivastava, R. Beniwal, B. Misra, Umaer Alam, H. Deval, Rajni Kant","doi":"10.4103/1995-7645.374352","DOIUrl":"https://doi.org/10.4103/1995-7645.374352","url":null,"abstract":"","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42596868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue positivity among blood donors in hyper-endemic region of southern India 印度南部高流行地区献血者登革热阳性率
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4103/1995-7645.374358
M. Ganesan, R. Sudha, G. Thangam, Sivathanu Lalitha
{"title":"Dengue positivity among blood donors in hyper-endemic region of southern India","authors":"M. Ganesan, R. Sudha, G. Thangam, Sivathanu Lalitha","doi":"10.4103/1995-7645.374358","DOIUrl":"https://doi.org/10.4103/1995-7645.374358","url":null,"abstract":"","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48271900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccine uptake and its determinants among teenagers and their parents in Zhejiang, China: An online cross-sectional study 中国浙江青少年及其父母新冠肺炎疫苗接种情况及其决定因素:一项在线横断面研究
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4103/1995-7645.374355
Yu Huang, Qingqing Wu, Shuiyang Xu, Xiang Zhao, Lei Wang, Qiaohong Lv, Suxian Wu, Xuehai Zhang
Objective: To examine COVID-19 vaccine uptake and its determinants among teenagers and their parents in Zhejiang, China. Methods: An online cross-sectional study was conducted among parents of teenagers in Zhejiang, China from May 1 to 31, 2022. Data were interpreted via univariate and multivariate analyses using the statistical package for the social sciences (SPSS) program. Results: A total of 11115 (96.11%) participants and 11449 (99.00%) of their children in Zhejiang, China had been vaccinated against COVID-19. Children whose parents did not receive COVID-19 vaccination were 19 times (aOR 18.96, 95%CI 12.36-29.08) more likely to be unvaccinated than their counterparts. In addition, children with no previous influenza vaccination, those whose parents doubted the COVID-19 vaccine’s safety or effectiveness, were 6.11 times (aOR 6.11, 95%CI 2.80-13.34), 8.27 times (aOR 8.27, 95%CI 5.33-12.83), and 2.69 times (aOR 2.69, 95%CI 1.11-6.50) more likely to be unvaccinated than their counterparts, respectively. COVID-19 vaccine uptake varied between different sociodemographic groups. However, the odds of receiving the COVID-19 vaccine decreased as age and education level increased. The main refusal reasons claimed by participants were that they had medical conditions that may not qualify them for vaccination (53.78%), followed by safety concerns about the vaccine (13.56%), not knowing where to get vaccinated (6.44%), and concerns about fertility issues (5.56%). Conclusions: Despite a highly encouraging level of COVID-19 vaccine uptake in Zhejiang, China, the elderly and highly educated people had lower COVID-19 vaccine uptake. It is suggested that tailored health education strategies should be taken to increase the COVID-19 vaccine uptake in such groups. Furthermore, with vaccination rates at such a high level, the pandemic is still ongoing, and public confidence in vaccines may decline. Thus, sufficient evidence-based information regarding COVID-19 vaccines should be provided to the public.
目的:了解浙江省青少年及其父母新冠肺炎疫苗接种情况及其影响因素。方法:于2022年5月1日至31日在浙江省青少年家长中进行在线横断面研究。使用社会科学统计软件包(SPSS)程序,通过单变量和多变量分析对数据进行解释。结果:中国浙江省共有11115名(96.11%)参与者及其子女11449人(99.00%)接种了新冠肺炎疫苗。父母未接种新冠肺炎疫苗的儿童未接种疫苗的可能性是其父母的19倍(aOR 18.96,95%CI 12.36-29.08)。此外,以前没有接种过流感疫苗的儿童,即父母怀疑新冠肺炎疫苗的安全性或有效性的儿童,未接种疫苗的可能性分别是同行的6.11倍(aOR 6.11,95%CI 2.80-13.34)、8.27倍(aOR8.27,95%CI 5.33-12.83)和2.69倍(aOr2.69,95%CI 1.11-6.50)。新冠肺炎疫苗接种情况因不同的社会人口群体而异。然而,随着年龄和教育水平的提高,接种新冠肺炎疫苗的几率降低。参与者声称的主要拒绝理由是,他们的身体状况可能不符合接种条件(53.78%),其次是对疫苗的安全性担忧(13.56%),不知道在哪里接种疫苗(6.44%),以及对生育问题的担忧(5.56%),老年人和受过高等教育的人新冠肺炎疫苗接种率较低。建议采取有针对性的健康教育策略,以提高这些群体对新冠肺炎疫苗的接种率。此外,由于疫苗接种率如此之高,疫情仍在持续,公众对疫苗的信心可能会下降。因此,应向公众提供足够的关于新冠肺炎疫苗的循证信息。
{"title":"COVID-19 vaccine uptake and its determinants among teenagers and their parents in Zhejiang, China: An online cross-sectional study","authors":"Yu Huang, Qingqing Wu, Shuiyang Xu, Xiang Zhao, Lei Wang, Qiaohong Lv, Suxian Wu, Xuehai Zhang","doi":"10.4103/1995-7645.374355","DOIUrl":"https://doi.org/10.4103/1995-7645.374355","url":null,"abstract":"Objective: To examine COVID-19 vaccine uptake and its determinants among teenagers and their parents in Zhejiang, China. Methods: An online cross-sectional study was conducted among parents of teenagers in Zhejiang, China from May 1 to 31, 2022. Data were interpreted via univariate and multivariate analyses using the statistical package for the social sciences (SPSS) program. Results: A total of 11115 (96.11%) participants and 11449 (99.00%) of their children in Zhejiang, China had been vaccinated against COVID-19. Children whose parents did not receive COVID-19 vaccination were 19 times (aOR 18.96, 95%CI 12.36-29.08) more likely to be unvaccinated than their counterparts. In addition, children with no previous influenza vaccination, those whose parents doubted the COVID-19 vaccine’s safety or effectiveness, were 6.11 times (aOR 6.11, 95%CI 2.80-13.34), 8.27 times (aOR 8.27, 95%CI 5.33-12.83), and 2.69 times (aOR 2.69, 95%CI 1.11-6.50) more likely to be unvaccinated than their counterparts, respectively. COVID-19 vaccine uptake varied between different sociodemographic groups. However, the odds of receiving the COVID-19 vaccine decreased as age and education level increased. The main refusal reasons claimed by participants were that they had medical conditions that may not qualify them for vaccination (53.78%), followed by safety concerns about the vaccine (13.56%), not knowing where to get vaccinated (6.44%), and concerns about fertility issues (5.56%). Conclusions: Despite a highly encouraging level of COVID-19 vaccine uptake in Zhejiang, China, the elderly and highly educated people had lower COVID-19 vaccine uptake. It is suggested that tailored health education strategies should be taken to increase the COVID-19 vaccine uptake in such groups. Furthermore, with vaccination rates at such a high level, the pandemic is still ongoing, and public confidence in vaccines may decline. Thus, sufficient evidence-based information regarding COVID-19 vaccines should be provided to the public.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41841304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis 含贝达奎林的个体方案对耐药结核病患者的早期疗效
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4103/1995-7645.372289
O. Putra, Yulistiani Yulistiani, S. Soedarsono, Susi Subay
Objective: To evaluate early efficacy of sputum conversion within 6 months of individual regimens containing bedaquiline in patients with drug resistant tuberculosis. Methods: We conducted a retrospective study among patients with drug resistant tuberculosis who were receiving individual regimens containing bedaquiline. The primary outcome was sputum conversion of both smear and culture within 6 months of treatment. We used medical records of drug resistant tuberculosis patients from January 2020 to December 2021. The study was conducted at Dr. Soetomo Hospital, Indonesia from August to October 2022. Results: In this study, 44 eligible drug resistant tuberculosis patients were initiated on regimens containing bedaquiline. There were 52.3% males and the median age was 45.5 years. The rates of previous treatment (70.5%) and lung cavity (36.4%) were high. The most common companion drugs included clofazimine, cycloserine, levofloxacin, and linezolid. Sputum smear and culture conversion was seen in 79.4% and 82.1% at the 2nd month, respectively. More than 97% patients had smear and culture conversion at the end of 6 months. Conclusions: Among drug resistant tuberculosis patients, individual regimens containing bedaquiline were associated with high rates of smear and culture conversion at the end of 6 months. Early efficacy of regimens containing bedaquiline can be used to predict cure rate at the end of treatment.
目的:评价含贝达奎林的个体方案治疗耐药肺结核6个月内转痰的早期疗效。方法:我们对接受含贝达奎林的个体治疗方案的耐药结核病患者进行了回顾性研究。主要结果是在治疗后6个月内,痰涂片和培养物均得到转化。我们使用了2020年1月至2021年12月耐药结核病患者的病历。该研究于2022年8月至10月在印度尼西亚Soetomo医生医院进行。结果:在本研究中,44名符合条件的耐药结核病患者开始接受含有贝达奎林的方案。男性52.3%,中位年龄45.5岁。既往治疗的发生率(70.5%)和肺空洞发生率(36.4%)较高。最常见的配套药物包括氯法齐明、环丝氨酸、左氧氟沙星和利奈唑胺。第2个月痰涂片和培养物转化率分别为79.4%和82.1%。超过97%的患者在6个月结束时进行了涂片和培养转化。结论:在耐药结核病患者中,含贝达奎林的个体方案与6个月底的高涂片和培养转化率相关。含有贝达奎林的方案的早期疗效可用于预测治疗结束时的治愈率。
{"title":"Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis","authors":"O. Putra, Yulistiani Yulistiani, S. Soedarsono, Susi Subay","doi":"10.4103/1995-7645.372289","DOIUrl":"https://doi.org/10.4103/1995-7645.372289","url":null,"abstract":"Objective: To evaluate early efficacy of sputum conversion within 6 months of individual regimens containing bedaquiline in patients with drug resistant tuberculosis. Methods: We conducted a retrospective study among patients with drug resistant tuberculosis who were receiving individual regimens containing bedaquiline. The primary outcome was sputum conversion of both smear and culture within 6 months of treatment. We used medical records of drug resistant tuberculosis patients from January 2020 to December 2021. The study was conducted at Dr. Soetomo Hospital, Indonesia from August to October 2022. Results: In this study, 44 eligible drug resistant tuberculosis patients were initiated on regimens containing bedaquiline. There were 52.3% males and the median age was 45.5 years. The rates of previous treatment (70.5%) and lung cavity (36.4%) were high. The most common companion drugs included clofazimine, cycloserine, levofloxacin, and linezolid. Sputum smear and culture conversion was seen in 79.4% and 82.1% at the 2nd month, respectively. More than 97% patients had smear and culture conversion at the end of 6 months. Conclusions: Among drug resistant tuberculosis patients, individual regimens containing bedaquiline were associated with high rates of smear and culture conversion at the end of 6 months. Early efficacy of regimens containing bedaquiline can be used to predict cure rate at the end of treatment.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49513484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A minor emphasis on the outbreak of cutaneous leishmaniasis after devastating earthquakes in Turkey 土耳其毁灭性地震后皮肤利什曼病的爆发
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372288
I. Ardic, N. Ardıç
{"title":"A minor emphasis on the outbreak of cutaneous leishmaniasis after devastating earthquakes in Turkey","authors":"I. Ardic, N. Ardıç","doi":"10.4103/1995-7645.372288","DOIUrl":"https://doi.org/10.4103/1995-7645.372288","url":null,"abstract":"","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45603182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID–19 vaccination and associated factors in Turkish healthcare workers practicing chest medicine 土耳其从事胸科医学的医护人员接种新冠肺炎疫苗及其相关因素
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372291
A. Sandal, Aylin Çifci, P. Arbak
Objective: To evaluate the COVID-19 vaccination status and related characteristics of Turkish healthcare workers practicing chest medicine. Methods: A cross-sectional online survey was conducted among the Turkish Thoracic Society members. The survey was started on May 17, 2021, and kept open for seven weeks. The 39-item survey included the COVID-19 vaccination status and demographic, clinical, and occupational characteristics. Results: Of 378 healthcare workers participated in the survey, 354 (93.7%) reported receiving at least one dose of the COVID-19 vaccine. A total of 323 (91.2%) healthcare workers received CoronaVac vs. BioNTech/Pfizer in 31 (8.8%). In the CoronaVac group, 77 (23.8%) contracted COVID-19 when not fully vaccinated, and 13 (4.0%) when fully vaccinated; however, 16 (51.6%) healthcare workers in the BioNTech/Pfizer group got COVID-19 when not fully vaccinated, but any fully vaccinated participants did not contract COVID-19 (P=0.003). Regarding vaccine dosing, 328 (86.8%) were fully vaccinated, while 50 (13.2%) were not. Multiple regression analysis for being a non-fully vaccinated healthcare worker demonstrated a significant relationship with having any SARS-CoV-2 infection history (adjusted OR 9.57, 95% CI 3.93-23.26, P<0.001) and being a non-physician healthcare worker (adjusted OR 5.86, 95% CI 2.11-16.26, P=0.001), but a significant negative relationship with full-time working at the time of survey (adjusted OR 0.13, 95% CI 0.03-0.56, P=0.006). Conclusions: Although a majority of healthcare workers were fully vaccinated, occupational and non-occupational characteristics were related to being non-fully vaccinated. Active surveillance regarding the COVID-19 vaccination in healthcare workers is necessary to address specific parameters as barriers to vaccination.
目的:了解土耳其胸科医护人员COVID-19疫苗接种情况及相关特点。方法:对土耳其胸科学会会员进行横断面在线调查。该调查于2021年5月17日开始,持续了7周。调查内容包括COVID-19疫苗接种状况、人口统计学、临床和职业特征。结果:参与调查的378名医护人员中,354名(93.7%)报告接种了至少一剂COVID-19疫苗。31年共有323名医护人员(91.2%)接受了CoronaVac,而BioNTech/辉瑞(8.8%)接受了CoronaVac。在CoronaVac组中,77人(23.8%)在未完全接种疫苗时感染了COVID-19, 13人(4.0%)在完全接种疫苗时感染了COVID-19;然而,BioNTech/Pfizer组的16名(51.6%)医护人员在未完全接种疫苗时感染了COVID-19,但任何完全接种疫苗的参与者都没有感染COVID-19 (P=0.003)。在疫苗剂量方面,328人(86.8%)完全接种了疫苗,50人(13.2%)没有接种。多元回归分析显示,未完全接种疫苗的卫生保健工作者与是否有SARS-CoV-2感染史(调整后的OR为9.57,95% CI为3.93-23.26,P<0.001)和非医师卫生保健工作者(调整后的OR为5.86,95% CI为2.11-16.26,P=0.001)有显著的负相关,但与调查时的全职工作有显著的负相关(调整后的OR为0.13,95% CI为0.03-0.56,P=0.006)。结论:尽管大多数卫生保健工作者接种了完全疫苗,但职业和非职业特征与未接种完全疫苗有关。有必要对卫生保健工作者的COVID-19疫苗接种情况进行积极监测,以解决作为疫苗接种障碍的特定参数。
{"title":"COVID–19 vaccination and associated factors in Turkish healthcare workers practicing chest medicine","authors":"A. Sandal, Aylin Çifci, P. Arbak","doi":"10.4103/1995-7645.372291","DOIUrl":"https://doi.org/10.4103/1995-7645.372291","url":null,"abstract":"Objective: To evaluate the COVID-19 vaccination status and related characteristics of Turkish healthcare workers practicing chest medicine. Methods: A cross-sectional online survey was conducted among the Turkish Thoracic Society members. The survey was started on May 17, 2021, and kept open for seven weeks. The 39-item survey included the COVID-19 vaccination status and demographic, clinical, and occupational characteristics. Results: Of 378 healthcare workers participated in the survey, 354 (93.7%) reported receiving at least one dose of the COVID-19 vaccine. A total of 323 (91.2%) healthcare workers received CoronaVac vs. BioNTech/Pfizer in 31 (8.8%). In the CoronaVac group, 77 (23.8%) contracted COVID-19 when not fully vaccinated, and 13 (4.0%) when fully vaccinated; however, 16 (51.6%) healthcare workers in the BioNTech/Pfizer group got COVID-19 when not fully vaccinated, but any fully vaccinated participants did not contract COVID-19 (P=0.003). Regarding vaccine dosing, 328 (86.8%) were fully vaccinated, while 50 (13.2%) were not. Multiple regression analysis for being a non-fully vaccinated healthcare worker demonstrated a significant relationship with having any SARS-CoV-2 infection history (adjusted OR 9.57, 95% CI 3.93-23.26, P<0.001) and being a non-physician healthcare worker (adjusted OR 5.86, 95% CI 2.11-16.26, P=0.001), but a significant negative relationship with full-time working at the time of survey (adjusted OR 0.13, 95% CI 0.03-0.56, P=0.006). Conclusions: Although a majority of healthcare workers were fully vaccinated, occupational and non-occupational characteristics were related to being non-fully vaccinated. Active surveillance regarding the COVID-19 vaccination in healthcare workers is necessary to address specific parameters as barriers to vaccination.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43747920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy 从布基纳法索返回的旅行者登革热和恶性疟疾合并感染:意大利东北部两例病例报告
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372294
A. Mastroianni, C. Vocale, V. Sambri, T. Lazzarotto, P. Gaibani, G. Rossini, S. Varani
Rationale: Malaria and dengue are the most prevalent vector-borne diseases in tropical countries. Plasmodium parasite and dengue virus (DENV) concurrent infection is possible and often under-recognized in geographical areas where these infections are both endemic. Patients concern and diagnosis: We describe the first two cases of Plasmodium falciparum and DENV-3 co-infection in travelers returning to northeastern Italy from Burkina Faso during 2013-2014. Interventions: Malaria infection in both patients was treated with mefloquine. Due to the persistence of symptoms despite of the antimalaria treatment, dengue was also investigated; the treatment of dengue was symptomatic. Outcomes: The patients were discharged in good general condition. Lessons: The need for surveillance of potential malaria and dengue co-infection in travelers returning to Europe from endemic areas is highlighted, as infection with Plasmodium does not exclude arboviral co-infection.
理由:疟疾和登革热是热带国家最常见的媒介传播疾病。疟原虫和登革热病毒(DENV)同时感染是可能的,并且在这些感染都是地方病的地理区域往往被低估。患者关注和诊断:我们描述了2013-2014年间从布基纳法索返回意大利东北部的旅行者中出现的前两例恶性疟原虫和登革病毒3型合并感染病例。干预措施:两名患者的疟疾感染均采用甲氟喹治疗。尽管进行了抗疟治疗,但由于症状持续存在,还对登革热进行了调查;登革热的治疗是有症状的。结果:患者出院时总体状况良好。经验教训:从流行地区返回欧洲的旅行者需要监测潜在的疟疾和登革热合并感染,因为疟原虫感染并不排除虫媒病毒合并感染。
{"title":"Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy","authors":"A. Mastroianni, C. Vocale, V. Sambri, T. Lazzarotto, P. Gaibani, G. Rossini, S. Varani","doi":"10.4103/1995-7645.372294","DOIUrl":"https://doi.org/10.4103/1995-7645.372294","url":null,"abstract":"Rationale: Malaria and dengue are the most prevalent vector-borne diseases in tropical countries. Plasmodium parasite and dengue virus (DENV) concurrent infection is possible and often under-recognized in geographical areas where these infections are both endemic. Patients concern and diagnosis: We describe the first two cases of Plasmodium falciparum and DENV-3 co-infection in travelers returning to northeastern Italy from Burkina Faso during 2013-2014. Interventions: Malaria infection in both patients was treated with mefloquine. Due to the persistence of symptoms despite of the antimalaria treatment, dengue was also investigated; the treatment of dengue was symptomatic. Outcomes: The patients were discharged in good general condition. Lessons: The need for surveillance of potential malaria and dengue co-infection in travelers returning to Europe from endemic areas is highlighted, as infection with Plasmodium does not exclude arboviral co-infection.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48016236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Knowledge, perceptions, and practice towards adverse events following immunization surveillance among vaccination workers in Zhejiang province, China 浙江省疫苗接种工作者对免疫监测后不良事件的认识、认知和实践
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372292
H. Lv, Xuejiao Pan, Ying Wang, H. Liang, Hu Yu
Objective: To access the level of knowledge, perceptions, and practice towards adverse events following immunization (AEFI) surveillance among vaccination workers in Zhejiang province, China. Methods: This was a cross-sectional survey involving 768 vaccination workers. Data were collected using self-administered questionnaires and analyzed by using SAS 9.3 software. Knowledge, perceptions, and practice on AEFI surveillance were summarized using frequency tables. The mean±SD value was used as the cut-off for defining good (values⩾mean) and poor (values
目的:了解浙江省疫苗接种工作人员对免疫接种后不良事件(AEFI)监测的知识、认知和实践水平。方法:这是一项涉及768名疫苗接种工作者的横断面调查。数据采用自填问卷收集,并使用SAS9.3软件进行分析。使用频率表总结了AEFI监测的知识、认知和实践。平均值±SD值被用作定义良好(值⩾平均值)和较差(值<平均值)知识、感知或实践的临界值。二元逻辑回归分析用于确定与AEFI的知识、认知和实践相关的社会人口学变量。结果:良好的AEFI监测知识、认知和实践比例分别为78.13%、57.81%和66.15%。具有较高的教育背景、较长的工作经验、既往接受过AEFI培训以及30岁是与疫苗接种工作者对AEFI监测的良好知识、看法和实践相关的因素。结论:超过一半的受访者对AEFI监测工作有良好的了解、认知和实践。应考虑采取干预措施,提高疫苗接种工作人员对AEFI监测的知识、看法和实践,以建立更有效的监测系统。
{"title":"Knowledge, perceptions, and practice towards adverse events following immunization surveillance among vaccination workers in Zhejiang province, China","authors":"H. Lv, Xuejiao Pan, Ying Wang, H. Liang, Hu Yu","doi":"10.4103/1995-7645.372292","DOIUrl":"https://doi.org/10.4103/1995-7645.372292","url":null,"abstract":"Objective: To access the level of knowledge, perceptions, and practice towards adverse events following immunization (AEFI) surveillance among vaccination workers in Zhejiang province, China. Methods: This was a cross-sectional survey involving 768 vaccination workers. Data were collected using self-administered questionnaires and analyzed by using SAS 9.3 software. Knowledge, perceptions, and practice on AEFI surveillance were summarized using frequency tables. The mean±SD value was used as the cut-off for defining good (values⩾mean) and poor (values<mean) knowledge, perceptions or practice. Binary logistic regression analysis was used to determine sociodemographic variables associated with knowledge, perceptions, and practice towards AEFI. Results: The proportions of good knowledge, perceptions and practice on AEFI surveillance were 78.13%, 57.81% and 66.15%, respectively. Having a higher education background, longer years of experience, previous training on AEFI and ⩾30 years of age were factors associated with good knowledge, perceptions and practice on AEFI surveillance among vaccination workers. Conclusions: Over half of the respondents had good knowledge, perceptions and practice on AEFI surveillance work. Interventions on improving the vaccination workers’ knowledge, perceptions and practice on AEFI surveillance should be considered in order to develop a more effective surveillance system.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45449084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Kenya should worry about Anopheles stephensi 肯尼亚为什么要担心斯氏按蚊
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372287
E. Owino
{"title":"Why Kenya should worry about Anopheles stephensi","authors":"E. Owino","doi":"10.4103/1995-7645.372287","DOIUrl":"https://doi.org/10.4103/1995-7645.372287","url":null,"abstract":"","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43243585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nigella sativa oil as a treatment for gingivitis: A randomized active–control trial Nigella sativa油治疗牙龈炎:一项随机主动对照试验
IF 3.1 4区 医学 Q2 Medicine Pub Date : 2023-03-01 DOI: 10.4103/1995-7645.372290
I. Rahman, Afrah A. Mohammed, M. AlSheddi, A. Algazlan, A. Alwably, M. Hebbal, Maha Omar
Objective: To assess the clinical anti-inflammatory and antimicrobial efficacy of Nigella sativa oil compared with chlorhexidine in patients with gingivitis. Methods: A double-blind, randomized clinical trial was conducted in patients having chronic generalized gingivitis. Patients were randomly assigned to receive Nigella sativa oil (n=18) or chlorhexidine (n=19). The following assessments were made on day 0 and day 15: plaque index, gingival index, gingival IL-6 and IL-18 levels were measured using ELISA, plaque colony-forming units, and alpha-hemolytic Streptococcus strains. Data were analyzed using parametric and non-parametric tests and Fisher's exact test. Results: Both interventions reduced plaque index and gingival index scores (P<0.000 1). The Nigella sativa oil group was better at lowering IL-6 (P=0.0076) than the chlorhexidine group (P=0.145), although there was no change in IL-18 levels (P>0.05). The post-intervention plaque index and gingival index scores and inflammatory cytokine levels between the two groups were not significantly different. Both interventions caused a significant reduction in the plaque colony-forming units (P<0.0001), reducing pathogenic bacteria: Streptococcus mitis, Streptococcus oralis, Streptococcus sanguinis, and Streptococcus parasanguinis in the chlorhexidine group (50%) (P=0.103 1), and the Nigella sativa oil group (20%) (P=0.739 5). Conclusions: Nigella sativa oil had anti-inflammatory and antibacterial activities, reducing biofilm formation and disrupting the colonization of pathogenic bacteria essential for the progression of periodontal disease. Nigella sativa oil could offer an alternative therapy for treating gingivitis and may prevent associated systemic diseases and improve overall health outcomes.
目的:比较苦艾油与氯己定治疗牙龈炎的临床抗炎抗菌效果。方法:对慢性全身性牙龈炎患者进行双盲、随机临床试验。患者被随机分配接受Nigella sativa油(n=18)或氯己定(n=19)。在第0天和第15天进行以下评估:使用ELISA、牙菌斑集落形成单位和α-溶血性链球菌菌株测量牙菌斑指数、牙龈指数、牙龈IL-6和IL-18水平。使用参数和非参数检验以及Fisher精确检验对数据进行分析。结果:两种干预措施均能降低牙菌斑指数和牙龈指数得分(P0.05),干预后两组牙菌斑指数、牙龈指数得分和炎症细胞因子水平差异无统计学意义。两种干预措施都导致斑块集落形成单位显著减少(P<0.0001),减少了致病菌:氯己定组(50%)的轻度链球菌、口腔链球菌、血链球菌和副血链球菌(P=0.1031),以及奈杰尔拉油组(20%)(P=0.739 5)。结论:Nigella sativa油具有抗炎和抗菌活性,减少了生物膜的形成,并破坏了牙周病进展所必需的病原菌的定植。Nigella sativa油可以为治疗牙龈炎提供一种替代疗法,并可以预防相关的系统性疾病,改善整体健康状况。
{"title":"Nigella sativa oil as a treatment for gingivitis: A randomized active–control trial","authors":"I. Rahman, Afrah A. Mohammed, M. AlSheddi, A. Algazlan, A. Alwably, M. Hebbal, Maha Omar","doi":"10.4103/1995-7645.372290","DOIUrl":"https://doi.org/10.4103/1995-7645.372290","url":null,"abstract":"Objective: To assess the clinical anti-inflammatory and antimicrobial efficacy of Nigella sativa oil compared with chlorhexidine in patients with gingivitis. Methods: A double-blind, randomized clinical trial was conducted in patients having chronic generalized gingivitis. Patients were randomly assigned to receive Nigella sativa oil (n=18) or chlorhexidine (n=19). The following assessments were made on day 0 and day 15: plaque index, gingival index, gingival IL-6 and IL-18 levels were measured using ELISA, plaque colony-forming units, and alpha-hemolytic Streptococcus strains. Data were analyzed using parametric and non-parametric tests and Fisher's exact test. Results: Both interventions reduced plaque index and gingival index scores (P<0.000 1). The Nigella sativa oil group was better at lowering IL-6 (P=0.0076) than the chlorhexidine group (P=0.145), although there was no change in IL-18 levels (P>0.05). The post-intervention plaque index and gingival index scores and inflammatory cytokine levels between the two groups were not significantly different. Both interventions caused a significant reduction in the plaque colony-forming units (P<0.0001), reducing pathogenic bacteria: Streptococcus mitis, Streptococcus oralis, Streptococcus sanguinis, and Streptococcus parasanguinis in the chlorhexidine group (50%) (P=0.103 1), and the Nigella sativa oil group (20%) (P=0.739 5). Conclusions: Nigella sativa oil had anti-inflammatory and antibacterial activities, reducing biofilm formation and disrupting the colonization of pathogenic bacteria essential for the progression of periodontal disease. Nigella sativa oil could offer an alternative therapy for treating gingivitis and may prevent associated systemic diseases and improve overall health outcomes.","PeriodicalId":8559,"journal":{"name":"Asian Pacific journal of tropical medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44480318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Pacific journal of tropical medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1